Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-02-02 Sale |
2023-02-06 5:01 pm |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Khattar Jack A. President, CEO |
13,732 | $42.05 | $577,492 | 1,902,376 (Indirect Direct) |
View |
| 2023-02-01 Sale |
2023-02-03 5:00 pm |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Khattar Jack A. President, CEO |
300 | $42.01 | $12,602 | 1,890,741 (Indirect Direct) |
View |
| 2023-01-31 Sale |
2023-02-02 5:00 pm |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Khattar Jack A. President, CEO |
976 | $42.01 | $41,002 | 1,891,041 (Indirect Direct) |
View |
| 2023-01-18 Sale |
2023-01-20 5:00 pm |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Khattar Jack A. President, CEO |
4,936 | $40.4 | $199,394 | 1,892,017 (Indirect Direct) |
View |
| 2023-01-17 Sale |
2023-01-19 5:00 pm |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Bhatt Padmanabh P. Sr. VP of IP, CSO |
4,826 | $39.92 | $192,638 | 6,644 (Direct) |
View |
| 2023-01-17 Sale |
2023-01-19 5:00 pm |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Khattar Jack A. President, CEO |
25,446 | $40.03 | $1,018,728 | 1,896,953 (Indirect Direct) |
View |
| 2023-01-06 Sale |
2023-01-09 5:00 pm |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Bhatt Padmanabh P. Sr. VP of IP, CSO |
174 | $39.9 | $6,943 | 11,470 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-02-23 Option Award |
2023-02-27 5:03 pm |
N/A 2033-02-23 |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Rubin Jonathan SVP, Chief Medical Officer |
25,000 | $0 | 27,497 (Direct) |
View |
| 2023-02-23 Option Award |
2023-02-27 5:03 pm |
N/A 2033-02-23 |
SUPERNUS PHARMACEUTICALS INC. | SUPN | DEC TIMOTHY C Senior Vice-President & CFO |
50,000 | $0 | 51,341 (Direct) |
View |
| 2023-02-23 Option Award |
2023-02-27 5:03 pm |
N/A 2033-02-23 |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Martin Tami Tillotson Sr. V.P., Regulatory Affairs |
25,000 | $0 | 115,323 (Direct) |
View |
| 2023-02-23 Option Award |
2023-02-27 5:02 pm |
N/A 2033-02-23 |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Khattar Jack A. President, CEO |
280,000 | $0 | 2,131,972 (Direct) |
View |
| 2023-02-23 Option Award |
2023-02-27 5:02 pm |
N/A 2033-02-23 |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Hudson Frederick M. Director |
10,179 | $0 | 45,046 (Direct) |
View |
| 2023-02-23 Option Award |
2023-02-27 5:02 pm |
N/A 2033-02-23 |
SUPERNUS PHARMACEUTICALS INC. | SUPN | NEWHALL CHARLES W III Director |
10,179 | $0 | 122,311 (Direct) |
View |
| 2023-02-23 Option Award |
2023-02-27 5:01 pm |
N/A 2033-02-23 |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Barlow Carrolee Director |
10,179 | $0 | 23,494 (Direct) |
View |
| 2023-02-23 Option Award |
2023-02-27 5:01 pm |
N/A 2033-02-23 |
SUPERNUS PHARMACEUTICALS INC. | SUPN | GEMAYEL GEORGES Director |
10,179 | $0 | 23,494 (Direct) |
View |
| 2023-02-23 Option Award |
2023-02-27 5:01 pm |
N/A 2033-02-23 |
SUPERNUS PHARMACEUTICALS INC. | SUPN | SIEBERT JOHN M Director |
10,179 | $0 | 94,236 (Direct) |
View |
| 2023-02-23 Option Award |
2023-02-27 5:00 pm |
N/A 2033-02-23 |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Mottola Frank SVP, Quality, GMP, Ops, IT |
37,500 | $0 | 47,017 (Direct) |
View |
| 2023-02-22 Option Award |
2023-02-24 5:16 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | SIEBERT JOHN M Director |
3,882 | $0 | 84,057 (Direct) |
View |
| 2023-02-22 Option Award |
2023-02-24 5:14 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | GEMAYEL GEORGES Director |
3,882 | $0 | 13,315 (Direct) |
View |
| 2023-02-22 Option Award |
2023-02-24 5:12 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Barlow Carrolee Director |
3,882 | $0 | 13,315 (Direct) |
View |
| 2023-02-22 Option Award |
2023-02-24 5:11 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Hudson Frederick M. Director |
3,882 | $0 | 34,867 (Direct) |
View |
| 2023-02-22 Option Award |
2023-02-24 5:08 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | NEWHALL CHARLES W III Director |
3,882 | $0 | 112,132 (Direct) |
View |
| 2023-02-22 Option Award |
2023-02-24 5:06 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Bhatt Padmanabh P. Sr. VP of IP, CSO |
750 | $0 | 5,497 (Direct) |
View |
| 2023-02-22 Option Award |
2023-02-24 5:03 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | DEC TIMOTHY C Senior Vice-President & CFO |
500 | $0 | 2,841 (Direct) |
View |
| 2023-02-22 Option Award |
2023-02-24 5:02 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Martin Tami Tillotson Sr. V.P., Regulatory Affairs |
750 | $0 | 92,573 (Direct) |
View |
| 2023-02-22 Option Award |
2023-02-24 5:01 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Mottola Frank SVP, Quality, GMP, Ops, IT |
750 | $0 | 11,767 (Direct) |
View |
| 2023-02-22 Option Award |
2023-02-24 5:00 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Rubin Jonathan SVP, Chief Medical Officer |
750 | $0 | 4,747 (Direct) |
View |
| 2023-02-16 Option Award |
2023-02-21 5:38 pm |
N/A 2023-04-01 |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Khattar Jack A. President, CEO |
20,000 | $0 | 1,871,972 (Direct) |
View |
| 2023-02-16 Tax Withholding |
2023-02-21 5:35 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Mottola Frank SVP, Quality, GMP, Ops, IT |
753 | $38.74 | 8,191 (Direct) |
View |
| 2023-02-16 Exercise |
2023-02-21 5:35 pm |
N/A 2031-04-30 |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Mottola Frank SVP, Quality, GMP, Ops, IT |
1,500 | $0 | 8,191 (Direct) |
View |
| 2023-02-16 Option Award |
2023-02-21 5:02 pm |
N/A 2023-04-01 |
SUPERNUS PHARMACEUTICALS INC. | SUPN | DEC TIMOTHY C Senior Vice-President & CFO |
1,500 | $0 | 1,500 (Direct) |
View |
| 2023-02-16 Exercise |
2023-02-21 5:01 pm |
N/A 2031-04-30 |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Martin Tami Tillotson Sr. V.P., Regulatory Affairs |
1,500 | $0 | 88,720 (Direct) |
View |
| 2023-02-16 Exercise |
2023-02-21 5:01 pm |
N/A 2031-04-30 |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Rubin Jonathan SVP, Chief Medical Officer |
1,500 | $0 | 1,500 (Direct) |
View |
| 2023-02-15 Other |
2023-02-16 5:00 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Khattar Jack A. President, CEO |
8,750 | $0 | 1,869,472 (Direct) |
View |
| 2018-04-17 Ownership |
2023-02-08 5:00 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | NEWHALL CHARLES W III Director |
2,203 | $0 | 108,250 (Direct) |
View |
| 2023-02-02 Exercise |
2023-02-06 5:01 pm |
N/A 2024-01-23 |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Khattar Jack A. President, CEO |
22,845 | $0 | 1,902,376 (Direct) |
View |
| 2023-02-02 Exercise |
2023-02-06 5:01 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Khattar Jack A. President, CEO |
22,845 | $9.56 | 1,902,376 (Direct) |
View |
| 2023-02-01 Exercise |
2023-02-03 5:00 pm |
N/A 2024-01-23 |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Khattar Jack A. President, CEO |
498 | $0 | 1,890,741 (Direct) |
View |
| 2023-02-01 Exercise |
2023-02-03 5:00 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Khattar Jack A. President, CEO |
498 | $9.56 | 1,890,741 (Direct) |
View |
| 2023-01-31 Exercise |
2023-02-02 5:00 pm |
N/A 2024-01-23 |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Khattar Jack A. President, CEO |
1,620 | $0 | 1,891,041 (Direct) |
View |
| 2023-01-31 Exercise |
2023-02-02 5:00 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Khattar Jack A. President, CEO |
1,620 | $9.56 | 1,891,041 (Direct) |
View |
| 2023-01-18 Exercise |
2023-01-20 5:00 pm |
N/A 2024-01-23 |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Khattar Jack A. President, CEO |
8,080 | $0 | 1,892,017 (Direct) |
View |
| 2023-01-18 Exercise |
2023-01-20 5:00 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Khattar Jack A. President, CEO |
8,080 | $9.56 | 1,892,017 (Direct) |
View |
| 2023-01-17 Exercise |
2023-01-19 5:00 pm |
N/A 2025-03-03 |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Bhatt Padmanabh P. Sr. VP of IP, CSO |
4,826 | $0 | 6,644 (Direct) |
View |
| 2023-01-17 Exercise |
2023-01-19 5:00 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Bhatt Padmanabh P. Sr. VP of IP, CSO |
4,826 | $9.13 | 6,644 (Direct) |
View |
| 2023-01-17 Exercise |
2023-01-19 5:00 pm |
N/A 2024-01-23 |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Khattar Jack A. President, CEO |
41,920 | $0 | 1,896,953 (Direct) |
View |
| 2023-01-17 Exercise |
2023-01-19 5:00 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Khattar Jack A. President, CEO |
41,920 | $9.56 | 1,896,953 (Direct) |
View |
| 2023-01-12 Option Award |
2023-01-17 5:03 pm |
N/A 2031-04-30 |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Mottola Frank SVP, Quality, GMP, Ops, IT |
1,500 | $0 | 8,944 (Direct) |
View |
| 2023-01-12 Option Award |
2023-01-17 5:02 pm |
N/A 2031-04-30 |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Martin Tami Tillotson Sr. V.P., Regulatory Affairs |
1,500 | $0 | 88,720 (Direct) |
View |
| 2023-01-12 Option Award |
2023-01-17 5:00 pm |
N/A 2031-04-30 |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Rubin Jonathan Sr. VP, Chief Medical Officer |
1,500 | $0 | 1,500 (Direct) |
View |
| 2022-03-14 Exercise(A) |
2023-01-13 5:00 pm |
N/A 2031-02-19 |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Khattar Jack A. President, CEO |
40,000 | $0 | 1,638,916 (Direct) |
View |
| 2022-03-14 Option Award(A) |
2023-01-13 5:00 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Khattar Jack A. President, CEO |
20,000 | $0 | 1,638,916 (Direct) |
View |
| 2021-07-30 Option Award(A) |
2023-01-13 5:00 pm |
N/A 2031-02-19 |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Khattar Jack A. President, CEO |
40,000 | $0 | 1,618,916 (Direct) |
View |
| 2023-01-10 Exercise |
2023-01-12 5:00 pm |
2014-02-05 2023-02-05 |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Hudson Frederick M. Director |
8,722 | $0 | 30,985 (Direct) |
View |
| 2023-01-10 Exercise |
2023-01-12 5:00 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Hudson Frederick M. Director |
8,722 | $7.9 | 30,985 (Direct) |
View |
| 2023-01-06 Exercise |
2023-01-09 5:00 pm |
N/A 2025-03-03 |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Bhatt Padmanabh P. Sr. VP of IP, CSO |
174 | $0 | 11,470 (Direct) |
View |
| 2023-01-06 Exercise |
2023-01-09 5:00 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Bhatt Padmanabh P. Sr. VP of IP, CSO |
174 | $9.13 | 11,470 (Direct) |
View |